400 related articles for article (PubMed ID: 15640801)
1. CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2.
Tai X; Cowan M; Feigenbaum L; Singer A
Nat Immunol; 2005 Feb; 6(2):152-62. PubMed ID: 15640801
[TBL] [Abstract][Full Text] [Related]
2. A function for interleukin 2 in Foxp3-expressing regulatory T cells.
Fontenot JD; Rasmussen JP; Gavin MA; Rudensky AY
Nat Immunol; 2005 Nov; 6(11):1142-51. PubMed ID: 16227984
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase B/Akt signals impair Th17 differentiation and support natural regulatory T cell function and induced regulatory T cell formation.
Pierau M; Engelmann S; Reinhold D; Lapp T; Schraven B; Bommhardt UH
J Immunol; 2009 Nov; 183(10):6124-34. PubMed ID: 19841181
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
5. Requirement of CD28 signaling in homeostasis/survival of TGF-beta converted CD4+CD25+ Tregs from thymic CD4+CD25- single positive T cells.
Liu Y; Amarnath S; Chen W
Transplantation; 2006 Oct; 82(7):953-64. PubMed ID: 17038912
[TBL] [Abstract][Full Text] [Related]
6. An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.
Hsieh CS; Zheng Y; Liang Y; Fontenot JD; Rudensky AY
Nat Immunol; 2006 Apr; 7(4):401-10. PubMed ID: 16532000
[TBL] [Abstract][Full Text] [Related]
7. Deacetylase inhibition promotes the generation and function of regulatory T cells.
Tao R; de Zoeten EF; Ozkaynak E; Chen C; Wang L; Porrett PM; Li B; Turka LA; Olson EN; Greene MI; Wells AD; Hancock WW
Nat Med; 2007 Nov; 13(11):1299-307. PubMed ID: 17922010
[TBL] [Abstract][Full Text] [Related]
8. A novel role for CD28 in thymic selection: elimination of CD28/B7 interactions increases positive selection.
Vacchio MS; Williams JA; Hodes RJ
Eur J Immunol; 2005 Feb; 35(2):418-27. PubMed ID: 15657954
[TBL] [Abstract][Full Text] [Related]
9. Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling.
D'Cruz LM; Klein L
Nat Immunol; 2005 Nov; 6(11):1152-9. PubMed ID: 16227983
[TBL] [Abstract][Full Text] [Related]
10. Lack of Foxp3 function and expression in the thymic epithelium.
Liston A; Farr AG; Chen Z; Benoist C; Mathis D; Manley NR; Rudensky AY
J Exp Med; 2007 Mar; 204(3):475-80. PubMed ID: 17353370
[TBL] [Abstract][Full Text] [Related]
11. Origin and T cell receptor diversity of Foxp3+CD4+CD25+ T cells.
Pacholczyk R; Ignatowicz H; Kraj P; Ignatowicz L
Immunity; 2006 Aug; 25(2):249-59. PubMed ID: 16879995
[TBL] [Abstract][Full Text] [Related]
12. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3.
Fontenot JD; Rudensky AY
Nat Immunol; 2005 Apr; 6(4):331-7. PubMed ID: 15785758
[TBL] [Abstract][Full Text] [Related]
13. Large-scale expansion of rat CD4+ CD25+ T(reg) cells in the absence of T-cell receptor stimulation.
Beyersdorf N; Balbach K; Hünig T; Kerkau T
Immunology; 2006 Dec; 119(4):441-50. PubMed ID: 16903867
[TBL] [Abstract][Full Text] [Related]
14. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
Kowolik CM; Topp MS; Gonzalez S; Pfeiffer T; Olivares S; Gonzalez N; Smith DD; Forman SJ; Jensen MC; Cooper LJ
Cancer Res; 2006 Nov; 66(22):10995-1004. PubMed ID: 17108138
[TBL] [Abstract][Full Text] [Related]
15. Aire and Foxp3 expression in a particular microenvironment for T cell differentiation.
Hansenne I; Louis C; Martens H; Dorban G; Charlet-Renard C; Peterson P; Geenen V
Neuroimmunomodulation; 2009 Jan; 16(1):35-44. PubMed ID: 19077444
[TBL] [Abstract][Full Text] [Related]
16. Role of bone marrow stromal cells in the generation of human CD8+ regulatory T cells.
Poggi A; Zocchi MR
Hum Immunol; 2008 Nov; 69(11):755-9. PubMed ID: 18817823
[TBL] [Abstract][Full Text] [Related]
17. A point mutation in CD28 distinguishes proliferative signals from survival signals.
Okkenhaug K; Wu L; Garza KM; La Rose J; Khoo W; Odermatt B; Mak TW; Ohashi PS; Rottapel R
Nat Immunol; 2001 Apr; 2(4):325-32. PubMed ID: 11276203
[TBL] [Abstract][Full Text] [Related]
18. Superagonistic anti-CD28 antibodies: potent activators of regulatory T cells for the therapy of autoimmune diseases.
Beyersdorf N; Hanke T; Kerkau T; Hünig T
Ann Rheum Dis; 2005 Nov; 64 Suppl 4(Suppl 4):iv91-5. PubMed ID: 16239397
[TBL] [Abstract][Full Text] [Related]
19. Regulation of CD28 expression on CD8+ T cells by CTLA-4.
Berg M; Zavazava N
J Leukoc Biol; 2008 Apr; 83(4):853-63. PubMed ID: 18162511
[TBL] [Abstract][Full Text] [Related]
20. Increased numbers of thymic and peripheral CD4+ CD25+Foxp3+ cells in the absence of CD5 signaling.
Ordoñez-Rueda D; Lozano F; Sarukhan A; Raman C; Garcia-Zepeda EA; Soldevila G
Eur J Immunol; 2009 Aug; 39(8):2233-47. PubMed ID: 19609976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
